IRONWOOD PHARMACEUTICALS INC (IRWD) Forecast, Price Target & Analyst Ratings

NASDAQ:IRWD • US46333X1081

Current stock price

3.37 USD
-0.01 (-0.3%)
At close:
3.47 USD
+0.1 (+2.97%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IRONWOOD PHARMACEUTICALS INC (IRWD).

Forecast Snapshot

Consensus Price Target

Price Target
$4.95
+ 46.80% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.17
Revenue Estimate
93.93M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.95
Upside
+ 46.80%
From current price of $3.37 to mean target of $4.95, Based on 10 analyst forecasts
Low
$0.71
Median
$5.46
High
$8.40

Price Target Revisions

1 Month
0.00%
3 Months
94.00%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for IRWD. The average price target is 4.95 USD. This implies a price increase of 46.8% is expected in the next year compared to the current price of 3.37.
The average price target has been revised upward by 94% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IRWD Current Analyst RatingIRWD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

IRWD Historical Analyst RatingsIRWD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
78.00%
IRWD was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about IRWD.
In the previous month the buy percentage consensus was at a similar level.
IRWD was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-26CitizensMaintains Market Outperform -> Market Outperform
2026-01-05CitizensUpgrade Market Perform -> Market Outperform
2026-01-05Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-11-11Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-04-15Wells FargoDowngrade Overweight -> Equal-Weight
2025-04-15JefferiesDowngrade Buy -> Hold
2025-04-14Leerink PartnersMaintains Market Perform -> Market Perform
2025-01-30JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-01-22Craig-HallumMaintains Buy -> Buy
2024-09-09Leerink PartnersInitiate Market Perform
2024-08-09Wells FargoMaintains Overweight -> Overweight
2024-08-09Craig-HallumMaintains Buy -> Buy
2024-05-10Craig-HallumMaintains Buy -> Buy
2024-03-01Wells FargoMaintains Overweight -> Overweight
2024-02-16Piper SandlerMaintains Overweight -> Overweight
2024-01-17Craig-HallumInitiate Buy
2023-12-14Wells FargoInitiate Overweight
2023-09-28JMP SecuritiesInitiate Market Outperform
2023-05-23Piper SandlerMaintains Overweight -> Overweight
2022-08-16Wells FargoMaintains Equal-Weight
2022-04-22Piper SandlerInitiate Overweight
2021-10-12Morgan StanleyMaintains Equal-Weight
2021-07-16Morgan StanleyMaintains Equal-Weight
2021-02-22Morgan StanleyMaintains Equal-Weight
2021-02-19Morgan StanleyMaintains Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.17
Revenue Estimate
93.93M
Revenue Q2Q
128.30%
EPS Q2Q
223.86%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
6.95%
Revenue (3 Months)
87.55%
EPS (1 Month)
385.71%
EPS (3 Months)
750.00%

Next Earnings Summary

IRWD is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.17 USD and the consensus revenue estimate is 93.93M USD.
The next earnings revenue estimate has been revised upward by 87.55% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IRWD revenue by date.IRWD revenue by date.
442.735M
7.83%		351.41M
-20.63%		296.151M
-15.72%		467.77M
57.95%		488.3M
4.39%		504.44M
3.31%		271.83M
-46.11%		172.89M
-36.40%		173.4M
0.29%		210.12M
21.18%		225.42M
7.28%
EBITDA
YoY % growth
IRWD ebitda by date.IRWD ebitda by date.
169.911M
-32.51%		97.728M
-42.48%		120.64M
23.44%		312.48M
159.02%		329.21M
5.35%		352.97M
7.22%		103.02M
-70.81%		-58.14M
-156.44%		-46.92M
19.30%		19.38M
141.30%		39.78M
105.26%
EBIT
YoY % growth
IRWD ebit by date.IRWD ebit by date.
168.336M
-32.76%		95.717M
-43.14%		118.759M
24.07%		293.05M
146.76%		312.99M
6.80%		197.88M
-36.78%		86.7M
-56.19%		-75.48M
-187.06%		-64.26M
14.86%		1.02M
101.59%		30.09M
2,850.00%
Operating Margin
IRWD operating margin by date.IRWD operating margin by date.
38.02%27.24%40.10%62.65%64.10%39.23%31.89%-43.66%-37.06%0.49%13.35%
EPS
YoY % growth
IRWD eps by date.IRWD eps by date.
0.64
-34.02%		0.02
-96.88%		0.23
1,050.00%		1.18
412.22%		1.34
13.85%		1.47
9.89%		0.50
-65.74%		-0.27
-152.53%		-0.15
42.31%		0.23
250.00%		0.33
44.44%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.17
223.86%		0.29
104.00%		0.36
48.75%		0.11
1,171.00%		-0.04
-123.53%		0.18
-35.71%		0.34
-5.71%		0.08
-23.81%
Revenue
Q2Q % growth		93.93M
128.30%		121.19M
42.18%		133.16M
9.09%		63.75M
33.62%		40.086M
-57.32%		93.432M
-22.90%		130.56M
-1.95%		69.768M
9.44%
EBITDA
Q2Q % growth		50.337M
595.00%		77.01M
67.35%		96.288M
21.72%		27.54M
226.54%		3.876M
-92.30%		57.222M
-25.70%		94.35M
-2.01%		33.558M
21.85%
EBIT
Q2Q % growth		45.747M
529.63%		72.42M
60.68%		90.168M
16.07%		19.38M
195.74%		-4.284M
-109.36%		49.062M
-32.25%		86.19M
-4.41%		25.398M
31.05%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IRWD Yearly Revenue VS EstimatesIRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M 500M
IRWD Yearly EPS VS EstimatesIRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
85.74%
EPS Next 5 Year
-25.82%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
18.23%
Revenue Next 5 Year
-10.75%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
50.56%
EBIT Next 5 Year
-20.70%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IRONWOOD PHARMACEUTICALS INC / IRWD Forecast FAQ

What is the price target for IRWD stock?

10 analysts have analysed IRWD and the average price target is 4.95 USD. This implies a price increase of 46.8% is expected in the next year compared to the current price of 3.37.

Can you provide the upcoming earnings date for IRONWOOD PHARMACEUTICALS INC?

IRONWOOD PHARMACEUTICALS INC (IRWD) will report earnings on 2026-05-05.

Can you provide the consensus estimates for IRONWOOD PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of IRONWOOD PHARMACEUTICALS INC (IRWD) is 0.17 USD and the consensus revenue estimate is 93.93M USD.

What is the consensus rating for IRWD stock?

The consensus rating for IRONWOOD PHARMACEUTICALS INC (IRWD) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.